January 17, 2025

Certain Vitamin D Dosages Could Reduce Risk of Autoimmune Diseases

Supplementation of 600–800IU per day of vitamin D could potentially reduce the risk of autoimmune diseases, reports a new meta-analysis.
January 17, 2025

Vitamin D and L-Cysteine Combination May Reduce Inflammation

Supplementation with vitamin D and L-cysteine could be more effective at increasing bioavailable vitamin D and reducing inflammation than taking vitamin D alone, according to a new study published in BMJ Nutrition, Prevention and Health.
January 17, 2025

Folic Acid May Protect Mothers and Children Against Liver Damage from Prenatal Chemical Exposure

Researchers have found that treating folic acid and other B vitamin deficiencies during pregnancy may help counter some of the adverse effects of prenatal chemical exposure on the livers of children.
January 10, 2025

Omega-3 Rich Diet and Fish Oil May Slow Prostate Cancer Growth

Findings published in the Journal of Clinical Oncology show that a diet low in omega-6 and high in omega-3 fatty acids, combined with fish oil supplements, significantly reduced the growth rate of prostate cancer cells in men with early-stage disease.
December 13, 2024

Vitamin C Can Boost Placental Health in Smokers

A new study demonstrates how vitamin C helps offset decreased placental blood flow found in pregnant mothers who smoke.
December 13, 2024

Study Shows Omega-3 Protects Against Heart Failure

People with higher omega-3 levels are significantly less likely to suffer or die from heart failure, according to findings published in the Mayo Clinic Proceedings journal.
December 6, 2024

France Proposes Slashing Maximum Levels of Vitamins and Minerals in Supplements

French regulators are proposing significant changes to permissible levels for vitamins and minerals in food supplements, which could see vitamin C limits slashed by almost 80 percent.
December 6, 2024

High-Dose IV Vitamin C Plus Chemotherapy Found to Double Survival Time in Advanced Pancreatic Cancer

Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from eight months to 16 months.